Establishing quality indicators to comprehensively assess quality assurance and patient safety in radiotherapy and their relationship with an institution's background.

Patient safety Quality assurance Quality control Quality indicators Radiotherapy Surveys and questionnaires

Journal

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
ISSN: 1879-0887
Titre abrégé: Radiother Oncol
Pays: Ireland
ID NLM: 8407192

Informations de publication

Date de publication:
02 2023
Historique:
received: 06 04 2022
revised: 11 12 2022
accepted: 18 12 2022
pubmed: 27 12 2022
medline: 3 3 2023
entrez: 26 12 2022
Statut: ppublish

Résumé

Quality indicators (QIs) for radiotherapy have been proposed by several groups, but no study has been conducted to correlate the implementation of indicators specific to patient safety over the course of the clinical process with an institution's background. An initial large-scale survey was conducted to understand the implementation status of QIs established for quality assurance and patient safety in radiotherapy and the relationship between implementation status and an institutions' background. Overall, 68 QIs that were established by this research team after a pilot survey were used to assess structures and processes for quality assurance and patient safety. Data on the implementation of QIs and the institutions' backgrounds were obtained from designated cancer care hospitals in Japan. Overall, 284 institutions (72 %) responded and had a median QI achievement rate of 60.8 %. QIs with low implementation rates, such as the implementation of an error reporting system and establishment of a quality assurance department, were identified. The QI achievement rate and scale of the institution were positively correlated, and the achievement rate of all QIs was significantly higher (p < 0.001) in institutions capable of advanced treatments, such as intensity-modulated radiotherapy, and those with a quality assurance department. A large-scale survey on QIs revealed their implementation and relationship with a facility's background. QIs that require improvement were identified, and that these QIs might be effective in providing advanced medical care to many patients.

Sections du résumé

BACKGROUND AND PURPOSE
Quality indicators (QIs) for radiotherapy have been proposed by several groups, but no study has been conducted to correlate the implementation of indicators specific to patient safety over the course of the clinical process with an institution's background. An initial large-scale survey was conducted to understand the implementation status of QIs established for quality assurance and patient safety in radiotherapy and the relationship between implementation status and an institutions' background.
MATERIALS AND METHOD
Overall, 68 QIs that were established by this research team after a pilot survey were used to assess structures and processes for quality assurance and patient safety. Data on the implementation of QIs and the institutions' backgrounds were obtained from designated cancer care hospitals in Japan.
RESULTS
Overall, 284 institutions (72 %) responded and had a median QI achievement rate of 60.8 %. QIs with low implementation rates, such as the implementation of an error reporting system and establishment of a quality assurance department, were identified. The QI achievement rate and scale of the institution were positively correlated, and the achievement rate of all QIs was significantly higher (p < 0.001) in institutions capable of advanced treatments, such as intensity-modulated radiotherapy, and those with a quality assurance department.
CONCLUSION
A large-scale survey on QIs revealed their implementation and relationship with a facility's background. QIs that require improvement were identified, and that these QIs might be effective in providing advanced medical care to many patients.

Identifiants

pubmed: 36572282
pii: S0167-8140(22)04604-7
doi: 10.1016/j.radonc.2022.109452
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

109452

Informations de copyright

Copyright © 2022 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Norifumi Mizuno (N)

Department of Radiation Oncology, St. Luke's International Hospital, Tokyo, Japan. Electronic address: mizunono@luke.ac.jp.

Hiroyuki Okamoto (H)

Radiation Safety and Quality Assurance Division, National Cancer Center Hospital, Tokyo, Japan. Electronic address: hiokamot@ncc.go.jp.

Toshiyuki Minemura (T)

Division of Medical Support and Partnership, Institute for Cancer Control, National Cancer Center, Tokyo, Japan. Electronic address: tminemur@ncc.go.jp.

Shinji Kawamura (S)

Graduate School of Health Sciences, Teikyo University, Fukuoka, Japan. Electronic address: kawamura@fmt.teikyo-u.ac.jp.

Naoki Tohyama (N)

Division of Medical Physics, Tokyo Bay Makuhari Clinic for Advanced Imaging, Cancer Screening, and High-Precision Radiotherapy, Chiba, Japan. Electronic address: naoki.tohyama@gmail.com.

Masahiko Kurooka (M)

Department of Radiation Therapy, Tokyo Medical University Hospital, Tokyo, Japan. Electronic address: kurooka.m@gmail.com.

Ryu Kawamorita (R)

Department of Radiation Oncology, Tane General Hospital, Osaka, Japan. Electronic address: kawamorita@tane.or.jp.

Masaru Nakamura (M)

Department of Radiology, Aichi Medical University Hospital, Aichi, Japan. Electronic address: mnakamur@aichi-med-u.ac.jp.

Yoshinori Ito (Y)

Department of Radiation Oncology, Showa University School of Medicine, Tokyo, Japan. Electronic address: yito@med.showa-u.ac.jp.

Yoshiyuki Shioyama (Y)

Ion Beam Therapy Center, SAGA-HIMAT Foundation, Saga, Japan. Electronic address: shioyama-yoshiyuki@saga-himat.jp.

Hidefumi Aoyama (H)

Department of Radiation Oncology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan. Electronic address: h-aoyama@major.ocn.ne.jp.

Hiroshi Igaki (H)

Department of Radiation Oncology, National Cancer Center Hospital, Tokyo, Japan. Electronic address: hirigaki@ncc.go.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH